Insider Trading: Catalyst Pharmaceutical Partners Inc (CPRX.O)

CPRX.O on Consolidated Issue listed on NASDAQ Capital Market

2.71USD
26 Nov 2014
Price Change (% chg)

$-0.02 (-0.73%)
Prev Close
$2.73
Open
$2.71
Day's High
$2.77
Day's Low
$2.69
Volume
153,310
Avg. Vol
1,277,788
52-wk High
$3.49
52-wk Low
$1.65

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
16 Oct 2014

Winship M Douglas

Officer Sell 45,363 $0.00
16 Oct 2014

Winship M Douglas

Officer Buy 125,000 $0.90
15 Oct 2014

Tierney David S

Director Buy 30,000 $0.90
2 Oct 2014

Muth David D

Officer Buy 10,000 $2.65
1 Oct 2014

Miller Steven R

Chief Operating Officer Buy 175,000 $0.90
1 Oct 2014

Huckel Hubert E

Director Sell 9,964 $0.00
1 Oct 2014

Coelho Philip H

Director Sell 9,964 $0.00
1 Oct 2014

Mcenany Patrick James

Chief Executive Officer Buy 150,000 $0.90
1 Oct 2014

Coelho Philip H

Director Buy 20,036 $0.90
1 Oct 2014

Grande Alicia

Chief Financial Officer Buy 90,000 $0.90
1 Oct 2014

O Keeffe Charles B

Director Buy 105,000 $0.90
1 Oct 2014

Huckel Hubert E

Director Buy 30,000 $0.90
3 Jun 2014

Miller Steven R

Chief Operating Officer Buy 100,000 $2.17
20 May 2014

Mcenany Patrick James

Chief Executive Officer Buy 25,000 $1.89
18 May 2014

O Keeffe Charles B

Director Buy 10,000 $1.83
15 Apr 2014

O Keeffe Charles B

Director Buy 5,000 $2.02
6 Feb 2014

Mcenany Patrick James

Chief Executive Officer Buy 25,000 $1.82
4 Feb 2014

O Keeffe Charles B

Director Buy 10,000 $1.81
22 Oct 2013

Tierney David S

Director Buy 8,000 $2.03
20 Oct 2013

Mcenany Patrick James

Chief Executive Officer Buy 50,000 $1.59
20 Oct 2013

O Keeffe Charles B

Director Buy 10,000 $1.84
18 Feb 2013

Mcenany Patrick James

Chief Executive Officer Buy 50,000 $0.46
16 Dec 2012

Mcenany Patrick James

Chief Executive Officer Buy 100,000 $0.45
7 Dec 2012

Biomarin Pharmaceutical Inc

Beneficial Owner of More than 10% Class Buy 5,000,000 $0.75

Institutional Holders

% Shares Owned: 35.92%
# of Holders: 56
Total Shares Held: 24,824,327
3 Mo. Net Change: 2,216,059
# New Positions: 19
# Closed Positions: 12
# Increased Positions: 30
# Reduced Positions: 25
# Net Buyers: 5

Officers & Directors

Name Age Since Current Position

Patrick McEnany

66 2006 Chairman of the Board, President, Chief Executive Officer

Alicia Grande

42 2011 Chief Financial Officer, Vice President, Treasurer

Steven Miller

52 2011 Chief Operating Officer, Chief Scientific Officer

David Muth

59 2014 Executive Vice President - Corporate Development

M. Douglas Winship

65 2006 Vice President - Regulatory Operations

David Caponera

2014 Vice President - Patient Advocacy & Reimbursement

Bernardino Mosquera

46 2013 Vice President - Clinical Operations

Charles O'Keeffe

74 2011 Lead Independent Director

Barrett McGrath

2014 Chief Commercial Officer

Philip Coelho

70 2002 Independent Director

Hubert Huckel

82 2006 Independent Director

David Tierney

50 2002 Independent Director

David Connolly

IR Contact Officer
Search Stocks